Evoke (LON:EVOK) Trading Down 10% – Should You Sell?

Evoke plc (LON:EVOKGet Free Report) fell 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).

Analyst Upgrades and Downgrades

EVOK has been the subject of several research analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank reduced their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.17) and set a “buy” rating on the stock in a research report on Wednesday, December 4th.

View Our Latest Research Report on Evoke

Evoke Trading Down 10.0 %

The company has a market capitalization of £230.70 million, a P/E ratio of -1.29 and a beta of 0.84. The stock’s fifty day moving average is GBX 69.32 and its 200 day moving average is GBX 63.58.

Evoke (LON:EVOKGet Free Report) last posted its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, analysts expect that Evoke plc will post 12.7648305 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Andrea Gisle Joosen acquired 14,572 shares of Evoke stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,206.11). 27.00% of the stock is currently owned by insiders.

About Evoke

(Get Free Report)

See Also

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.